These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 2170136)
21. Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro. Eriksson BF; Schinazi RF Antimicrob Agents Chemother; 1989 May; 33(5):663-9. PubMed ID: 2546487 [TBL] [Abstract][Full Text] [Related]
22. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine against human cytomegalovirus when administered as single-bolus dose and continuous infusion in in vitro cell culture perfusion system. Moore MR; Hamzeh FM; Lee FE; Lietman PS Antimicrob Agents Chemother; 1994 Oct; 38(10):2404-8. PubMed ID: 7840578 [TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2'-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Gordon YJ; Romanowski E; Araullo-Cruz T; Seaberg L; Erzurum S; Tolman R; De Clercq E Antiviral Res; 1991 Jul; 16(1):11-6. PubMed ID: 1776874 [TBL] [Abstract][Full Text] [Related]
24. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. Maggs DJ; Clarke HE Am J Vet Res; 2004 Apr; 65(4):399-403. PubMed ID: 15077679 [TBL] [Abstract][Full Text] [Related]
25. A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors. Bedard J; May S; Barbeau D; Yuen L; Rando RF; Bowlin TL Antiviral Res; 1999 Feb; 41(1):35-43. PubMed ID: 10321577 [TBL] [Abstract][Full Text] [Related]
26. Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations. Baldanti F; Biron KK; Gerna G J Infect Dis; 1998 Mar; 177(3):823-4. PubMed ID: 9498475 [No Abstract] [Full Text] [Related]
27. Design and SAR study of a novel class of nucleotide analogues as potent anti-HCMV agents. Nguyen-Ba N; Chan L; Quimpère M; Turcotte N; Lee N; Mitchell H; Bédard J Nucleosides Nucleotides; 1999; 18(4-5):821-7. PubMed ID: 10432685 [TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir. Harada K; Eizuru Y; Isashiki Y; Ihara S; Minamishima Y Arch Virol; 1997; 142(2):215-25. PubMed ID: 9125039 [TBL] [Abstract][Full Text] [Related]
29. Immunotoxic potential of antiviral drugs: effects of ganciclovir and (S)-1-(3-hydroxy-2-phosphonylmethoxy propyl) cytosine on lymphocyte transformation and delayed-type hypersensitivity responses. Simecka JW; Patel P; Kern ER Antiviral Res; 1992 May; 18(1):53-64. PubMed ID: 1416903 [TBL] [Abstract][Full Text] [Related]
30. Activities of various compounds against murine and primate polyomaviruses. Andrei G; Snoeck R; Vandeputte M; De Clercq E Antimicrob Agents Chemother; 1997 Mar; 41(3):587-93. PubMed ID: 9055998 [TBL] [Abstract][Full Text] [Related]
31. Chemotherapy of the acquired immune deficiency syndrome (AIDS): acyclic nucleoside phosphonate analogues. De Clercq E Int J Immunopharmacol; 1991; 13 Suppl 1():91-8. PubMed ID: 1823910 [TBL] [Abstract][Full Text] [Related]
32. Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect. Otová B; Votruba I; Holý A Acta Virol; 1992 May; 36(3):313-9. PubMed ID: 1360759 [TBL] [Abstract][Full Text] [Related]
33. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) inhibits HIV-1 replication in epithelial cells, but not T-lymphocytes. Srinivas RV; Connely M; Fridland A Antiviral Res; 1997 Jun; 35(1):23-7. PubMed ID: 9224958 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of African swine fever virus DNA synthesis by (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine. Arzuza O; García-Villalón D; Tabarés E; Gil-Fernández C; De Clercq E Biochem Biophys Res Commun; 1988 Jul; 154(1):27-32. PubMed ID: 3395330 [TBL] [Abstract][Full Text] [Related]
35. Tyrosine-based 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) prodrugs: synthesis, stability, antiviral activity, and in vivo transport studies. Zakharova VM; Serpi M; Krylov IS; Peterson LW; Breitenbach JM; Borysko KZ; Drach JC; Collins M; Hilfinger JM; Kashemirov BA; McKenna CE J Med Chem; 2011 Aug; 54(16):5680-93. PubMed ID: 21812420 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue. Bidanset DJ; Rybak RJ; Hartline CB; Kern ER Antiviral Res; 2004 Jul; 63(1):61-4. PubMed ID: 15196821 [TBL] [Abstract][Full Text] [Related]
37. Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine. Stals FS; Zeytinoglu A; Havenith M; de Clercq E; Bruggeman CA Antimicrob Agents Chemother; 1993 Feb; 37(2):218-23. PubMed ID: 8383939 [TBL] [Abstract][Full Text] [Related]
38. Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents. Neyts J; Snoeck R; Schols D; Himpens B; De Clercq E J Virol Methods; 1991 Nov; 35(1):27-38. PubMed ID: 1666112 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication. Keith KA; Hitchcock MJ; Lee WA; Holý A; Kern ER Antimicrob Agents Chemother; 2003 Jul; 47(7):2193-8. PubMed ID: 12821467 [TBL] [Abstract][Full Text] [Related]
40. Comparative activity of various compounds against clinical strains of herpes simplex virus. Andrei G; Snoeck R; Goubau P; Desmyter J; De Clercq E Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):143-51. PubMed ID: 1327785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]